/Baxter%20International%20Inc_%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of $17.9 billion, Illinois-based Baxter International Inc. (BAX) is a global leader in medical technology. It specializes in renal care, medication delivery, pharmaceuticals, and kidney care solutions. The company is expected to announce its fiscal Q2 earnings results on Thursday, Jul. 25.
Ahead of the event, analysts expect BAX to report a profit of $0.66 per share, up 20% from $0.55 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on one other occasion. Strong demand for its infusion pumps and dialysis products helped the company surpass the consensus EPS estimate by 6.6% in the most recent quarter.